Market Research & Insights
Workforce gaps in Australian MedTech, Pharma, Biotech and digital health sectors

Australia’s medical technology, biotechnology, pharmaceutical and digital health sector supports approximately 70,000 Australian jobs and contributed more than $5 billion in Gross Value Added (GVA) to the Australian economy in 2019. Its future is dependent on the skills of its workforce.
Earlier this year, MTPConnect set out to better understand the sector’s workforce needs and skills gaps by funding some sector research.
Working with the support of a cross-industry project team of AusBiotech, ANDHealth, Medical Technology Association of Australia (MTAA) and Medicines Australia, an online survey of human resource (HR) professionals and managers with hiring responsibilities in the sector was developed to find out more.
The results of the survey are in and BehaviourWorks Australia, a research enterprise within the Monash Sustainable Development Institute has prepared the following report, ‘A Survey of Workforce Skills and Capacity in the Medical Technology, Biotechnology, Pharmaceutical and Digital Health (MTP) Sector’.
This report identifies current, emerging and future skills gaps that need to be addressed in order to drive employment and growth in the Australian MTP sector, including:
- Business skills and commercial expertise
- Regulation and quality
- Clinical (including trials)
- Biological sciences and technologies
- Informatics, computation, mathematical and statistics and;
- Chemical science
Feedback concerning the lack of real-world experience in industry shows there is more work to be done to support career development opportunities in our sector.
These survey results have now been incorporated into a comprehensive Skills Gap Analysis being undertaken by L.E.K for MTPConnect’s REDI program.
REDI is a four-year $32 million MRFF funded program which aims to build the MTP workforce, address skills gaps and enhance entrepreneurship in Australia. An interim Skills Gap Analysis report will be released next month.
News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science

The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More